hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-11. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
=== Secondary structure === Roughly 7 alpha helices are predicted for C3orf62 through Pele Protein Structure Protein Prediction and strengthened through orthologous secondary structure predictions by Ali2D.
Adrenomedullin (ADM) is a peptide hormone that plays an important role in various physiological processes throughout the human body. Initially discovered in 1993 from a pheochromocytoma, a tumor of the adrenal medulla, this 52-amino acid peptide is now recognized for its diverse effects, including vasodilation, regulation of blood pressure, and maintenance of the vascular system. ADM is widely expressed in tissues and also found in the circulation, exerting its influence on the cardiovascular, lymphatic, and endocrine systems, as well as demonstrating anti-inflammatory and tissue-protective properties. In humans, ADM is encoded by the ADM gene. A similar peptide named adreomedullin2 was reported in rats in 2004, which exhibits a similar function.
GvpA is a gas vesicle structural protein found in different phyla of bacteria and archaea for example in Halobacterium salinarum or Haloferax mediterranei. Gas vesicles are small, hollow, gas filled protein structures found in several cyanobacterial and archaebacterial microorganisms. They allow the positioning of the bacteria at a favourable depth for growth. GvpA associates with GvpC, to build up gas vesicles, hollow protein structures which are used by planktonic organisms to perform vertical migration. GvpA makes up most of the structure, as so called "ribs", rigid β-sheets, whereas GvpC stabilizes the vesicle against collapse by crosslinking as α-helices.
Ca2+ + 2 HCO−3 → CaCO3↓ + CO2 + H2O At seawater pH, most of the dissolved CO2 is immediately converted back into HCO−3. The reaction results in a net transport of one molecule of CO2 from the ocean/atmosphere into the lithosphere. The result is that each Ca2+ ion released by chemical weathering ultimately removes one CO2 molecule from the surficial system (atmosphere, ocean, soil and living organisms), storing it in carbonate rocks where it is likely to stay for hundreds of millions of years. The weathering of calcium from rocks thus scrubs CO2 from the ocean and air, exerting a strong long-term effect on climate.
Sources: en.wikipedia.org
Southern Rhodesia's main contribution to the Burma Campaign in terms of manpower was made by the Rhodesian African Rifles (RAR), a regiment of black troops led by white officers that joined the front at the end of 1944. The colony also made a significant contribution to the Commonwealth forces' command element in Burma, providing white officers and NCOs to the 81st (West Africa), 82nd (West Africa) and 11th (East Africa) Divisions, made up of units from Nigeria, the Gold Coast, the Gambia, Sierra Leone, Kenya, Uganda, Tanganyika, Nyasaland, Northern Rhodesia and the Congo. Almost every African battalion in Burma had white Rhodesian officers and NCOs attached; some were over 70% Rhodesian-led. Modelled on the Rhodesia Native Regiment of World War I, the RAR was formed in May 1940 under the command of Lieutenant-Colonel F J Wane, who the black soldiers nicknamed msoro-we-gomo ("top of the mountain"). Most volunteers for the regiment came from Mashonaland, much to the surprise of the white recruiters, who had expected Matabeleland, with stronger martial traditions, to provide more men. Originally comprising one battalion, the RAR expanded to two battalions in late 1943 to accommodate a rush of new recruits following the news that the 1st Battalion was being deployed overseas.
=== Mortars === Two-inch mortar – Fielded until the 1980s ML 3-inch mortar – in service through to the 1960s L16 81mm mortar – Main Cold War mortar. ML 4.2-inch mortar – saw service in 1960s L10A1 51mm mortar – Introduced in the 1980s
Major (Acting Lieutenant Colonel) Graham Evan William Tudor Raikes (510624), Adjutant General's Corps (SPS). 24565384 Warrant Officer Class 2 John Joseph Richards, Adjutant General's Corps (RMP). W0801011 Staff Sergeant Sandra Robson, The Royal Logistic Corps. Major Philip James Francois Schofield (495231), The Royal Green Jackets. Major Michael Peter Shapland (504505), Royal Tank Regiment. Major Alistair Colin Sheppard (508235), Corps of Royal Engineers. Acting Lieutenant Colonel Robin Fitzroy Somerset (414981), Winchester College Combined Cadet Force, Territorial Army. 24386268 Warrant Officer Class 2 Kevin Stewart, Royal Regiment of Artillery. Captain John Sutherland (537667), The Highlanders. Major Leslie Harris-Ward, , (502300), The Parachute Regiment (Volunteers), Territorial Army. Major Robert William Warren (513382), Adjutant General's Corps (RMP). Overseas Award Lieutenant Wong Hon Wing (538568), General List. Royal Air Force Flight Sergeant Ronald John Bennett (D8011572). Flight Lieutenant Ian Michael Beresford (8151887). Warrant Officer George Arthur Biddleston (D8068720). Sergeant Karl Richard Brown (D8126056). Flight Lieutenant (now Squadron Leader) Stephen John Butler (8080431). Squadron Leader Sean Chiddention (8028456). Flight Lieutenant Andrew Cubin (8027993). Flight Lieutenant Neil Cummings (3145881), Royal Air Force Volunteer Reserve (Training). Corporal Anthony David Deacon (R8198216). Squadron Leader Brian Dean (4278701), (Retired). Junior Technician Peter Doherty (E8254300). Corporal Christine Doyley (E8233551).
=== High potassium levels === Spironolactone can cause high blood potassium levels. Rarely, this can be fatal. Of people with heart disease prescribed typical dosages of spironolactone, 10 to 15% develop some degree of hyperkalemia, and 6% develop severe hyperkalemia. At a higher dosage, a rate of hyperkalemia of 24% has been observed. An abrupt and major increase in the rate of hospitalization due to hyperkalemia from 0.2 to 11% and in the rate of death due to hyperkalemia from 0.3 to 2.0 per 1,000 between early 1994 and late 2001 has been attributed to a parallel rise in the number of prescriptions written for spironolactone upon the publication of the Randomized Aldactone Evaluation Study (RALES) in July 1999. However, another population-based study in Scotland failed to replicate these findings. The risk of hyperkalemia with spironolactone is greatest in the elderly, in people with renal impairment (e.g., due to chronic kidney disease or diabetic nephropathy), in people taking certain other medications (including ACE inhibitors, angiotensin II receptor blockers, nonsteroidal anti-inflammatory drugs, the antibiotic trimethoprim, and potassium supplements), and at higher dosages of spironolactone.
=== 23 May === In its evening report, the Ukrainian military reported that there were 25 air strikes and 20 incidents of shelling reported across the country for the day, but no missile attacks. Yevgeny Prigozhin, head of the Wagner Group, promised to transfer control of the Ukrainian city of Bakhmut to the Russian army by 1 June. In an interview, he said that more than 20,000 of his fighters died in the battle for the city, and acknowledged that the Russian military had killed civilians. President Zelenskyy visited naval infantry troops along the Vuhledar-Maryinka defence line in Donetsk Oblast as part of commemorations of the Day of the Ukrainian Marines. He announced that new marine brigades would be added to the Ukrainian military's existing units. The governor of Donetsk Oblast said Russian aerial bombs struck Toretsk, damaging a school but causing no casualties. The Russian Ministry of Defence said that it had forced back "nationalists" who had launched the cross-border attacks in Belgorod Oblast back into Ukraine, adding that its forces had killed more than 70 "Ukrainian terrorists" and destroyed four armored combat vehicles and five pickups. The Governor of Russia's Kursk Oblast said three villages bordering Ukraine were left without power after a drone dropped explosives on an electrical substation. Ukraine accused Russia of blocking access to the port of Pivdennyi to grain exports despite the resumption of the Black Sea Grain Initiative.
Sources: en.wikipedia.org
Danaparoid, a mixture of heparan sulfate, dermatan sulfate, and chondroitin sulfate can be used as an anticoagulant in patients having developed HIT. Because danaparoid does not contain heparin or heparin fragments, cross-reactivity of danaparoid with heparin-induced antibodies is reported as less than 10%. The effects of heparin are measured in the lab by the activated partial thromboplastin time (aPTT), one of the measures of the time it takes the blood plasma to clot. Partial thromboplastin time should not be confused with prothrombin time, or PT, which measures blood clotting time through a different pathway of the coagulation cascade.
Many countries control Salvia divinorum in some manner. As of 2015, it is illegal in Australia, Belgium, parts of Canada, Croatia, Czech Republic, Denmark, Germany, Hong Kong, Italy, Japan, Latvia, Lithuania, Poland, Portugal, Republic of Ireland, Romania, South Korea, Sweden, and Switzerland. It is legal to possess and grow in Chile, France and Spain, but not to sell. In Russia, it is legal to possess, but not grow or sell. Estonia, Finland, Iceland, and Norway treat it as a medicinal herb that requires a prescription. The prohibitive degree of Salvia divinorum legislation varies widely from country to country. Australia has imposed its strictest 'schedule 9' (US Schedule I equivalent), and Italy has also placed salvia in its 'Table I' of controlled substances (also US Schedule I equivalent). In Spain, there are controls focusing only on the commercial trade of Salvia divinorum, personal cultivation (i.e. for non-commercial use) is not targeted. Legislation may prove difficult to enforce. The plant has a nondescript appearance; unlike many other drug plants, the leaves are non-descript, and without a detectable odour. Salvia divinorum can be grown as an ordinary houseplant without the need of special equipment such as hydroponics or high-power lights.
The dendritic cells are activated in the presence of tumor antigens, which may be a single tumor-specific peptide/protein or a tumor cell lysate (a solution of broken-down tumor cells). These cells (with optional adjuvants) are infused and provoke an immune response. Dendritic cell therapies include the use of antibodies that bind to receptors on the surface of dendritic cells. Antigens can be added to the antibody and can induce the dendritic cells to mature and provide immunity to the tumor. Dendritic cell receptors such as TLR3, TLR7, TLR8 or CD40 have been used as antibody targets. Dendritic cell-NK cell interface also has an important role in immunotherapy. The design of new dendritic cell-based vaccination strategies should also encompass NK cell-stimulating potency. It is critical to systematically incorporate NK cells monitoring as an outcome in antitumor DC-based clinical trials.
=== Rocks === These are asteroids and other non-planetary bodies hollowed out for habitation and usually spun for centrifugal artificial gravity. Rocks (with the exception of those used for secretive purposes) are described as having faster-than-light space drives, and thus can be considered a special form of spaceship. Like Orbitals, they are usually administered by one or more Minds. Rocks do not play a large part in most of the Culture stories, though their use as storage for mothballed military ships (Pittance) and habitats (Phage Rock, one of the founding communities of the Culture) are both key plot points in Excession.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.